These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 26576088)

  • 41. Screening and treatment for hepatocellular carcinoma.
    Sherman M; Takayama Y
    Gastroenterol Clin North Am; 2004 Sep; 33(3):671-91, xi. PubMed ID: 15324950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatocellular carcinoma: diagnosis, management, and prognosis.
    Page AJ; Cosgrove DC; Philosophe B; Pawlik TM
    Surg Oncol Clin N Am; 2014 Apr; 23(2):289-311. PubMed ID: 24560111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
    van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The diagnosis and treatment of hepatocellular carcinoma.
    Hartke J; Johnson M; Ghabril M
    Semin Diagn Pathol; 2017 Mar; 34(2):153-159. PubMed ID: 28108047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy.
    Debes JD; Chan AJ; Balderramo D; Kikuchi L; Gonzalez Ballerga E; Prieto JE; Tapias M; Idrovo V; Davalos MB; Cairo F; Barreyro FJ; Paredes S; Hernandez N; Avendaño K; Diaz Ferrer J; Yang JD; Carrera E; Garcia JA; Mattos AZ; Hirsch BS; Gonçalves PT; Carrilho FJ; Roberts LR
    Liver Int; 2018 Jan; 38(1):136-143. PubMed ID: 28640517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multidisciplinary approach for HCC patients: hepatology for the oncologists.
    Barone C; Koeberle D; Metselaar H; Parisi G; Sansonno D; Spinzi G
    Ann Oncol; 2013 Apr; 24 Suppl 2():ii15-23. PubMed ID: 23715939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.
    Hong TP; Gow P; Fink M; Dev A; Roberts S; Nicoll A; Lubel J; Kronborg I; Arachchi N; Ryan M; Kemp W; Knight V; Farrugia H; Thursfield V; Desmond P; Thompson AJ; Bell S
    Hepatology; 2016 Apr; 63(4):1205-12. PubMed ID: 26435297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Management of hepatocellular carcinoma].
    Pache I; Bize P; Halkic N; Montemurro M; Giostra E; Majno P; Moradpour D
    Rev Med Suisse; 2010 Jan; 6(233):198-202. PubMed ID: 20214192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatocellular carcinoma and other liver lesions.
    Salgia R; Singal AG
    Med Clin North Am; 2014 Jan; 98(1):103-18. PubMed ID: 24266917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment options in hepatocellular carcinoma today.
    Livraghi T; Mäkisalo H; Line PD
    Scand J Surg; 2011; 100(1):22-9. PubMed ID: 21482502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatocellular carcinoma from the view of gastroenterologist/hepatologist.
    Petr U; Petr H
    Klin Onkol; 2020; 33(Supplementum 3):34-44. PubMed ID: 33213164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.
    Sherman M
    Semin Liver Dis; 2010 Feb; 30(1):3-16. PubMed ID: 20175029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current management strategies for hepatocellular carcinoma.
    Czaja AJ
    Minerva Gastroenterol Dietol; 2013 Jun; 59(2):143-59. PubMed ID: 23831906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M; Zhao J; Lu F
    Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis C and hepatocellular carcinoma.
    Fassio E
    Ann Hepatol; 2010; 9 Suppl():119-22. PubMed ID: 20714008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Shaping the future management of hepatocellular carcinoma.
    Abou-Alfa G; Colombo M
    Semin Liver Dis; 2013 Feb; 33 Suppl 1():S20-3. PubMed ID: 23457036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advanced HCC: emerging molecular therapies.
    Finn RS
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):25-34. PubMed ID: 22419002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatocellular carcinoma.
    Marrero JA
    Curr Opin Gastroenterol; 2006 May; 22(3):248-53. PubMed ID: 16550039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Viral hepatitis and hepatocellular carcinoma.
    Sallie R; Di Bisceglie AM
    Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.